Target- |
Mechanism- |
|
Originator Org.- |
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
常通口服液预防手术后腹腔粘连安全性和有效性的多中心、随机、双盲、安慰剂平行对照、IIIa期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled, phase IIIa clinical trial of the safety and efficacy of Changtong Oral Liquid in preventing postoperative intraperitoneal adhesions
评价常通口服液用于腹部手术患者术后预防腹膜粘连的安全性与有效性。
[Translation] To evaluate the safety and efficacy of Changtong Oral Liquid for postoperative prevention of peritoneal adhesions in patients with abdominal surgery.
抑乳调经颗粒在健康女性志愿者中单次给药耐受性和安全性的开放、剂量递增的I期临床试验
[Translation] An open-label, dose-escalating phase I clinical trial of Yiru Tiaojing Granules in healthy female volunteers for single-dose tolerability and safety
评估在健康女性志愿者中,单次口服抑乳调经颗粒10 g、20 g、30 g、 或 40 g 后的安全性和耐受性。
[Translation] To evaluate the safety and tolerability of a single oral administration of 10 g, 20 g, 30 g, or 40 g of YRUTiaojing Granules in healthy female volunteers.
常通口服液防治手术后腹膜粘连的有效性和安全性Ⅱ期 临床试验
[Translation] Phase II clinical trial of efficacy and safety of Changtong Oral Liquid in preventing and treating postoperative peritoneal adhesions
1.评价常通口服液用于单纯性阑尾炎、急性化脓性阑尾炎、慢性阑尾炎或因子宫肌瘤而行腹式全子宫切除术、腹式子宫次全切术的腹部手术患者术后腹膜粘连的临床防治效果。 2.评价常通口服液用于腹部手术患者术后腹膜粘连的安全性与不良反应。
[Translation] 1. To evaluate the effect of Changtong Oral Liquid on postoperative peritoneal adhesions in patients with simple appendicitis, acute suppurative appendicitis, chronic appendicitis or abdominal surgery for abdominal hysterectomy and abdominal subtotal hysterectomy due to uterine fibroids. Clinical control effect. 2. To evaluate the safety and adverse reactions of Changtong Oral Liquid for postoperative peritoneal adhesions in patients with abdominal surgery.
100 Clinical Results associated with Guangzhou Sanyi Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Guangzhou Sanyi Biomedical Technology Co., Ltd.
100 Deals associated with Guangzhou Sanyi Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Guangzhou Sanyi Biomedical Technology Co., Ltd.